Kermit, the coffee table cat
Kermit, the coffee table cat Read More »
For years ATS customers have been Gangsta and Kermit fans, and now it is time to show your love by adding a caption to Kermit’s picture! Each quarter we will post a picture of Kermit up to his usual hijinks and ask our readership to offer their most creative captions. Be clever and creative as Kermit
Kermit Judges from on High Read More »
ATS is pleased to present a new product line specific for the vesicular GABA transporter (vGAT) protein. vGAT mediates both the accumulation of GABA into synaptic vesicles and its release from nerve terminals. vGAT is expressed in nerve endings of GABAergic neurons throughout the CNS. The GABAergic system is crucial to the development and functional
Toolbox: vGAT Products Read More »
CHOp75 Cells 192-IgG-SAP is the #1 rat p75-lesioning tool available for research use. Our development of CHOp75 cells grew from the need for a stable, reliable cell line to use for Quality Control of each new lot of 192-IgG-SAP. Now, these cells are available for use in laboratories worldwide. CHOp75 cells are standard CHO (Chinese
Toolbox: Stable Transfected Cell Lines Read More »
The fundamental things apply. “The Peptidergic Control Circuit for Sighing,” recently published in the prestigious journal Nature, has made us rethink our fundamental belief that sighs are only “long, deep breaths expressing sadness, relief or exhaustion.” Often prompting someone to say, “What’s wrong?” As it turns out, sighs “also occur spontaneously every few minutes to
From the President: A Sigh is (Not) Just a Sigh . . . Read More »
by Ronald G. Wiley, M.D., Ph.D., Departments of Neurology and Pharmacology, Vanderbilt University, Nashville, TN and C. J. Vierck, Department of Neuroscience, McKnight Brain Institute, University of Florida College of Medicine, Gainesville, FL, USA Degeneration of the cholinergic basal forebrain (CBF: medial septum, diagonal band of Broca, nucleus basalis of Meynert/substantia innominata) is a prominent
A quick update on the pursuit of conditional approval of SP-SAP to treat bone cancer pain in dogs. The FDA has already approved Minor Use/Minor Species (MUMS) designation for the drug, providing extended market exclusivity to treat the >10,000 annual cases of canine bone cancer-related pain, and the ability to commercialize the drug as soon
Veterinary Development of Substance P-Saporin (SP-SAP) Read More »
We are proud to announce the release of our newly redesigned website. It has been crafted to reflect content our customers access most often and to provide new visitors an easier way to learn about ATS’s products and services. Immediately you will notice streamlined menus, simple navigation and access to the information you need, any
Targeting Tools: Brand New Website Read More »
In an effort to accelerate offering new targeted toxins to our customers, we launched the Beta Product program early in 2015. Publications and collaborations are an invaluable source of independent data to support the efficacy of our products. To help streamline this process, we’ve created a catalog of new targeted toxins that we’re offering to
Targeting Tools: Beta Products Read More »